Table 2 Mean utility (EQ-5D) values extrapolated from MSQ and HIT-6
Week, mean (SD) | Placebo | Erenumab 70 mg | Erenumab 140 mg | |||
|---|---|---|---|---|---|---|
MSQ | HIT-6 | MSQ | HIT-6 | MSQ | HIT-6 | |
0 | 0.615 (0.173) | 0.671 (0.136) | 0.633 (0.163) | 0.677 (0.125) | 0.617 (0.176) | 0.675 (0.145) |
4 | 0.675 (0.161) | 0.721 (0.135) | 0.716 (0.142) | 0.747 (0.125) | 0.716 (0.154) | 0.761 (0.147) |
8 | 0.687 (0.160) | 0.732 (0.137) | 0.726 (0.141) | 0.771 (0.133) | 0.729 (0.153) | 0.775 (0.147) |
12 | 0.687 (0.160) | 0.734 (0.139) | 0.730 (0.146) | 0.776 (0.134) | 0.737 (0.144) | 0.787 (0.145) |
16 | 0.736 (0.120) | 0.781 (0.119) | 0.765 (0.111) | 0.810 (0.122) | 0.775 (0.094) | 0.828 (0.114) |
20 | 0.731 (0.127) | 0.786 (0.128) | 0.771 (0.100) | 0.813 (0.121) | 0.776 (0.093) | 0.824 (0.114) |
24 | 0.729 (0.129) | 0.781 (0.132) | 0.763 (0.111) | 0.812 (0.122) | 0.776 (0.091) | 0.824 (0.114) |